Skip to main content

WisdomTree BioRevolution Fund (WDNA)

BATS: WDNA · Delayed Price · USD
24.04
-0.11 (-0.45%)
At close: Nov 29, 2021 4:00 PM
24.04
0.00 (0.00%)
After-hours:Nov 29, 2021 8:00 PM EST
Assetsn/a
NAVn/a
Expense Ration/a
PE Ration/a
Shares Outn/a
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
1-Year Return
Volume22
Open25.00
Previous Close24.15
Day's Range24.04 - 24.45
52-Week Low24.66
52-Week High24.66
Betan/a
Holdings111
Inception DateJun 3, 2021

About WDNA

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index ("index"). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Stock ExchangeBATS
Ticker SymbolWDNA

Top 10 Holdings

16.78% of assets
NameSymbolWeight
AstraZenecaAZN1.92%
BioNTech SEBNTX1.81%
RepligenRGEN1.77%
PerkinElmerPKI1.72%
Eli Lilly and CompanyLLY1.70%
PfizerPFE1.69%
Thermo Fisher ScientificTMO1.67%
DanaherDHR1.55%
ZoetisZTS1.52%
QiagenQGEN1.44%
View More Holdings

News

Historic Opportunity Afoot in Biotech Investing

Some market pundits love clarion calls and hyperbole, but there are times when credibly rare opportunities do emerge. That might be happening today with biotech, genomics, and other next-generation heal...

3 weeks ago - ETF Trends

As New Healthcare Era Dawns, Consider WDNA

Investors looking for sector-level innovation beyond the technology realm don't need to stretch into unfamiliar territory — healthcare is prime territory for disruptive growth concepts. Several exchange...

1 month ago - ETF Trends

All Aboard for the BioRevolution!

By Jamie Metzl & Jeremy Schwartz, WisdomTree Discussing the investing opportunity of one of the 21st century's defining megatrends  WisdomTree has collaborated with Dr. Jamie Metzl to help create the Wi...

2 months ago - ETF Trends

Embrace WDNA as BioRevolution Gains Momentum

Investors looking for innovative companies and disruptive growth opportunities without excessive exposure to the technology sector would do well to check out healthcare. Arguably, healthcare is the most...

2 months ago - ETF Trends

The WDNA ETF: Investing in Healthcare Innovation

As has been widely noted over the past 18 months, the coronavirus pandemic has accelerated dramatic shifts in a myriad of sectors and industries. One of the obvious members of that group is healthcare.

3 months ago - ETF Trends

The BioRevolution: An ETF That Taps Into Nearly Everything

Exchange traded fund investors should consider the current opportunities in healthcare innovation. In the recent webcast, The Era of Biotech: How Biology Became Technology, Jeremy Schwartz, Executive Vi...

5 months ago - ETF Trends

The Era of Biotech: How Biology Became Technology

First was the industrial revolution, then came the information era with the Internet; next up are genetics and biotechnology. New megatrends help steer the way the global economy develops.

5 months ago - ETF Trends